TrialThoracic cancer2025

Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single-Arm Study.

Xiaoyi Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.